These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2006121)
61. Inhibition of tumor growth and enhancement of metastasis after transfection of the gamma-interferon gene. Lollini PL; Bosco MC; Cavallo F; De Giovanni C; Giovarelli M; Landuzzi L; Musiani P; Modesti A; Nicoletti G; Palmieri G Int J Cancer; 1993 Sep; 55(2):320-9. PubMed ID: 8370628 [TBL] [Abstract][Full Text] [Related]
62. Induction of urokinase activity and malignant phenotype in bladder carcinoma cells after transfection of the activated Ha-ras oncogene. Brunner G; Pohl J; Erkell LJ; Radler-Pohl A; Schirrmacher V J Cancer Res Clin Oncol; 1989; 115(2):139-44. PubMed ID: 2654132 [TBL] [Abstract][Full Text] [Related]
63. Oncogene induction of metastases. Liotta LA Ciba Found Symp; 1988; 141():94-108. PubMed ID: 3075939 [TBL] [Abstract][Full Text] [Related]
64. Radiosensitivity of HCV cells and their v-ras and v-raf transfectants. Kowalczyk D; Skierski J; Koronkiewicz M; Janik P Mutat Res; 2000 Nov; 454(1-2):63-9. PubMed ID: 11035160 [TBL] [Abstract][Full Text] [Related]
65. Spontaneous metastatic potential of rat hepatocarcinoma cells after cell fusion or DNA transfection. Cassingena R; Lafarge-Frayssinet C; Frayssinet C; Nardeux P; Estrade S; Viegas-Pequignot E; Dutrillaux B Int J Cancer; 1992 Jan; 50(2):238-45. PubMed ID: 1309725 [TBL] [Abstract][Full Text] [Related]
66. Correlation of growth capacity of cells in hard agarose with successful transfection by the activated c-Ha-ras oncogene and in vivo proliferative capacity at metastatic sites. Fidler IJ; Li LM; Ananthaswamy HN; Esumi N; Radinsky R; Price JE Anticancer Res; 1991; 11(1):17-24. PubMed ID: 2018350 [TBL] [Abstract][Full Text] [Related]
67. The effect of E1A transfection on MMP-9 expression and metastatic potential. Bernhard EJ; Hagner B; Wong C; Lubenski I; Muschel RJ Int J Cancer; 1995 Mar; 60(5):718-24. PubMed ID: 7860147 [TBL] [Abstract][Full Text] [Related]
68. The identification of osteopontin as a metastasis-related gene product in a rodent mammary tumour model. Oates AJ; Barraclough R; Rudland PS Oncogene; 1996 Jul; 13(1):97-104. PubMed ID: 8700559 [TBL] [Abstract][Full Text] [Related]
69. Transfected c-Ha-ras oncogene enhances karyotypic instability and integrates predominantly in aberrant chromosomes. de Vries JE; Kornips FH; Marx P; Bosman FT; Geraedts JP; ten Kate J Cancer Genet Cytogenet; 1993 May; 67(1):35-43. PubMed ID: 8504397 [TBL] [Abstract][Full Text] [Related]
70. Cytogenetic analysis of three rat liver epithelial cell lines (WBneo, WBHa-ras, and WBrasIIa) and correlation of an early chromosomal alteration with insulin-like growth factor II expression. Sargent L; Dragan YP; Babcock K; Wiley J; Klaunig J; Pitot HC Cancer Res; 1996 Jul; 56(13):2992-7. PubMed ID: 8674053 [TBL] [Abstract][Full Text] [Related]
71. Different metastatic potentials of ras- and src-transformed BALB/c 3T3 A31 variant cells. Tatsuka M; Ota T; Yamagishi N; Kashihara Y; Wada M; Matsuda N; Mitsui H; Seiki M; Odashima S Mol Carcinog; 1996 Apr; 15(4):300-8. PubMed ID: 8634088 [TBL] [Abstract][Full Text] [Related]
72. Production of metastatic phenotype with DNA from metastatic cells but not with oncogenic DNA. Jamieson S; Barraclough R; Rudland PS Cell Biol Int Rep; 1990 Aug; 14(8):717-25. PubMed ID: 2171786 [TBL] [Abstract][Full Text] [Related]
73. Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Ichikawa T; Ichikawa Y; Dong J; Hawkins AL; Griffin CA; Isaacs WB; Oshimura M; Barrett JC; Isaacs JT Cancer Res; 1992 Jun; 52(12):3486-90. PubMed ID: 1596907 [TBL] [Abstract][Full Text] [Related]
75. NK sensitivity, H-2, c-K-ras proto-oncogene expression and metastases: analysis of the metastatic potential of H-2 gene transfected fibrosarcoma cells. Rager-Zisman B; Gopas J; Bar-Eli M; Har-Vardi I; Hammerling GJ; Segal S Adv Exp Med Biol; 1988; 233():151-60. PubMed ID: 3066149 [TBL] [Abstract][Full Text] [Related]
76. c-K-ras overexpression is characteristic for metastases derived from a methylcholanthrene-induced fibrosarcoma. Algarra I; Perez M; Serrano MJ; Garrido F; Gaforio JJ Invasion Metastasis; 1998-1999; 18(5-6):261-70. PubMed ID: 10729771 [TBL] [Abstract][Full Text] [Related]
77. c-fos transfection of 3LL tumor cells turns on MHC gene expression and consequently reduces their metastatic competence. Kushtai G; Feldman M; Eisenbach L Int J Cancer; 1990 Jun; 45(6):1131-6. PubMed ID: 2351488 [TBL] [Abstract][Full Text] [Related]
78. Different malignant phenotypes induced in a stable, subdiploid, benign epithelial clone by DNA transfection. Gibbins JR; Nicholson TR; Vozab RJ; Ying B; Messerle KR Anticancer Res; 1991; 11(1):129-37. PubMed ID: 1708218 [TBL] [Abstract][Full Text] [Related]
79. A model to study c-myc and v-H-ras induced prostate cancer progression in the Copenhagen rat. Lehr JE; Pienta KJ; Yamazaki K; Pilat MJ Cell Mol Biol (Noisy-le-grand); 1998 Sep; 44(6):949-59. PubMed ID: 9763199 [TBL] [Abstract][Full Text] [Related]
80. Counter-selection for over-expressed human CD44s in primary tumors versus lung metastases in a mouse fibrosarcoma model. Kogerman P; Sy MS; Culp LA Oncogene; 1997 Sep; 15(12):1407-16. PubMed ID: 9333016 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]